Outcome of azacitidine therapy in acute myeloid leukaemia is not improved by concurrent vorinostat therapy but is predicted by a diagnostic molecular signature
Charles Craddock, Aimee Houlton, Lynn Quek, Paul Ferguson, Emmanouela Gbandi, Corran Roberts, Marlen Metzner, Natalia Garcia-Martin, Alison Kennedy, Angela Hamblin, Manoj Raghavan, Sandeep Nagra, Louise Hopkins, Keith Wheatley, Mary Frances McMullin, Srinivas Pillai, Richard Kelly, Shamyla Siddique, Michael Dennis, Jamie D. CavenaghParesh Vyas
Research output: Contribution to journal › Article › peer-review
39Citations
(Scopus)
194Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Outcome of azacitidine therapy in acute myeloid leukaemia is not improved by concurrent vorinostat therapy but is predicted by a diagnostic molecular signature'. Together they form a unique fingerprint.